Call for Abstract submissions is now closed. Thank you for your submissions.

Note: A conflict of interest disclosure is mandatory for all presenters at the time of abstract submission.

A condition of acceptance is that the presenting author must register for the conference. Registration must be received by February 5, 2018 in order for the abstract to be accepted and included in the Final Program.

ownload Call for Abstracts

Abstract Format 

Abstract submissions will be reviewed for either oral or poster presentation. When submitting an abstract, you will have a choice to select your preference for:

• Oral presentation*
• Poster presentation

*Note, Those selecting an oral presentation will be asked if they will accept a poster presentation if an oral presentation is not available.

Three poster sessions are planned during the conference as indicated in the conference schedule.

Abstract Topics 

All abstracts submitted should address one of the conference topics for inclusion in the program. When submitting an abstract, please select the topic that your abstract applies to from the list below.

1. UV exposure, skin cancer risk, and human health
2. Vitamin D and sun protection
3. Effective UV prevention strategies
4. Indoor tanning trends and prevention
5. Effective communication strategies in workplaces, schools, and communities;
6. Novel research methods and measures for skin cancer prevention
7. Population-based screening for melanoma
8. Dermatology/pediatric dermatology
9. Costs related to skin cancer prevention
10. Dissemination of evidence-based programs and practices
11. Policy development and implementation
12. Culture and social factors in skin cancer and its prevention
13. Environmental planning and design for UV protection and skin cancer prevention

Deadline for Submissions has been extended to: Friday, December 15, 2017

Notice of adjudication will be provided by Thursday, January 15, 2018. Initial correspondence will be addressed to the submitting author. Unless requested otherwise, after acceptance, correspondence will then be directed to the designated presenting author.

Full presentation guidelines will be sent in February 2018. A condition of acceptance is that the presenter must register for the conference by February 5, 2018, in order for the abstract to be included in the Final Program.

Permission to Publish

Please be advised that authors grant exclusive license to the Conference for any reproduction as it sees fit. Submission of your abstract and acceptance to present constitutes your consent to publication.

Submitting an Abstract Online

The online submission system is now closed. Thank you for your submissions.

Those abstracts selected for poster or oral presentations will be reproduced exactly as submitted and substitutions will not be permitted. Be sure to proofread your abstract very carefully before submitting.

Conflict of Interest Disclosure 

A conflict of interest disclosure is mandatory for all presenters at the time of abstract submission.

Disclosures should identify all commercial relationships, financial or otherwise, in the last two years regardless of whether or not they relate to the topic presented. These disclosures must be meaningful by indicating the type(s) of relationship that has (have) taken place. This may include, but not limited to, the following:

• Advisory Board
• Board of Directors
• Clinical Trials Investigator
• Consultant
• Employee
• Founder
• Gifts or In-kind Compensation
• Grants
• Honoraria
• Patent Inventor / Holder
• Shareholder
• Speaker Bureau
• Website / Publications